Holen Sie sich die Stockscreener-App
1.91
3.05%
-0.06
Schlusskurs vom Vortag:
$1.97
Offen:
$2
24-Stunden-Volumen:
1.11M
Relative Volume:
0.63
Marktkapitalisierung:
$559.38M
Einnahmen:
$6.23M
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-4.8974
EPS:
-0.39
Netto-Cashflow:
$-68.47M
1W Leistung:
-2.55%
1M Leistung:
+61.86%
6M Leistung:
+60.50%
1J Leistung:
+34.51%
1-Tages-Spanne:
$1.87
$2.05
1-Wochen-Bereich:
$1.87
$2.17
52-Wochen-Spanne:
$0.6513
$2.17
Precigen Inc Stock (PGEN) Company Profile
Firmenname
Precigen Inc
Sektor
Branche
Telefon
301-556-9900
Adresse
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Vergleichen Sie PGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
1.91 | 559.38M | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Eingeleitet | JP Morgan | Neutral |
| 2022-11-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-02-25 | Eingeleitet | Stifel | Buy |
| 2021-02-22 | Eingeleitet | Wells Fargo | Overweight |
| 2021-02-18 | Eingeleitet | B. Riley Securities | Buy |
| 2020-05-08 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Precigen Inc Aktie (PGEN) Neueste Nachrichten
Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy? - Nasdaq
Precigen (NASDAQ:PGEN) Reaches New 1-Year HighStill a Buy? - MarketBeat
Precigen (NASDAQ:PGEN) Stock Price Up 8.4%What's Next? - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Price Target from Brokerages - Defense World
Precigen (NASDAQ:PGEN) Hits New 52-Week HighHere's What Happened - MarketBeat
Will Precigen's Treatment For Recurrent Respiratory Papillomatosis Cross The FDA Finish Line? - RTTNews
SG Americas Securities LLC Acquires 12,578 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
PGEN Stock Soars to 52-Week High, Reaching $1.93 Amid Growth - MSN
Precigen, Inc. (NASDAQ:PGEN) Shares Bought by Iridian Asset Management LLC CT - MarketBeat
These Numbers Prove Just How Vibrant The Precigen Inc (NASDAQ: PGEN) Stock Has Been - Stocks Register
Precigen (NASDAQ:PGEN) Shares Up 7.8%Here's Why - MarketBeat
Precigen stock slides after pricing stock offering to raise $30 million - MSN
Exploring 3 High Growth Tech Stocks in the United States - Simply Wall St
Precigen Inc (NASDAQ: PGEN): Performance Review And Forecast - Marketing Sentinel
Precigen: Successful Proof Of Platform, But Cash Worries Remain (NASDAQ:PGEN) - Seeking Alpha
Precigen (NASDAQ:PGEN) Stock Price Up 7.8% – Time to Buy? - Armenian Reporter
PGEN Shares Experience Surge in Value - Knox Daily
Precigen Inc (NASDAQ: PGEN): Can A Stock Be Up 42.86% YTD, And Still Be A Loser - Marketing Sentinel
A Deep Dive into Precigen Inc (PGEN) Stock Performance - The InvestChronicle
JP Morgan analysts downgrades an Underweight rating for Precigen Inc (PGEN) - Knox Daily
Is Precigen Inc (PGEN) a good investment opportunity? - US Post News
Precigen, Inc. (NASDAQ:PGEN) Shares Sold by JPMorgan Chase & Co. - MarketBeat
JPMorgan Chase & Co. Decreases Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World
FY2024 EPS Estimates for Precigen Lifted by HC Wainwright - Defense World
HC Wainwright Has Weak Outlook for Precigen FY2026 Earnings - Defense World
Precigen’s (PGEN) Buy Rating Reiterated at HC Wainwright - Defense World
Investors Purchase High Volume of Call Options on Precigen (NASDAQ:PGEN) - MarketBeat
LexAurum Advisors LLC Raises Stock Holdings in Precigen, Inc. (NASDAQ:PGEN) - MarketBeat
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright - MarketBeat
Precigen (NASDAQ:PGEN) Earns Buy Rating from HC Wainwright - MarketBeat
Precigen Sees Unusually Large Options Volume (NASDAQ:PGEN) - Defense World
Precigen's SWOT analysis: biotech firm's stock poised for growth with PRGN-2012 - MSN
Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday - Benzinga
Precigen (NASDAQ:PGEN) Given Buy Rating at HC Wainwright - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Stock Position Increased by Barclays PLC - Defense World
Analysts Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $6.33 - Defense World
Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Precigen, Inc. Regains Compliance with Nasdaq Listing Rules - Defense World
Precigen shares rebound above Nasdaq minimum bid price - MSN
Precigen shares rebound above Nasdaq minimum bid price By Investing.com - Investing.com Australia
Should You Invest in Precigen (PGEN)? - MSN
Finanzdaten der Precigen Inc-Aktie (PGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Precigen Inc-Aktie (PGEN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| KIRK RANDAL J | Director |
Aug 09 '24 |
Buy |
0.85 |
23,529,411 |
19,999,999 |
64,547,214 |
| KIRK RANDAL J | Director |
Mar 09 '24 |
Option Exercise |
0.00 |
213,675 |
0 |
32,051,461 |
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):